News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
James Davis: Ide-cel vs cilita-cel in R/R multiple myeloma
James Davis/X
Feb 23, 2025, 10:27

James Davis: Ide-cel vs cilita-cel in R/R multiple myeloma

James Davis, Assistant professor & malignant hematology pharmacist at MUSC Hollings Cancer Center, shared an article by Doris K. Hansen, et al. on X:

“In lieu of a head-to-head trial comparing ide-cel and cilta-cel (which we will never get), check out our study in Journal of Clinical Oncology comparing these products in over 600 patients.

Congrats Doris Hansen, Krina Patel, Surbhi Sidana, Danai Dima, Charlotte B Wagner.”

Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.

Authors: Doris K. Hansen, et al.

James Davis: Ide-cel vs cilita-cel in R/R multiple myeloma

 

cancer CharlotteBWagner Ciltacabtagene Autoleucel Danai Dima Doris Hansen Doris K. Hansen fight against cancer Global fight against cancer idecabtagene vicleucel James Davis Journal of Clinical Oncology Krina Patel multiple myeloma MUSC Hollings Cancer Center OncoDaily Oncology Surbhi Sidana
Special Coverage
Blog
May 9, 2025, 10:37
Yuji Uehara: Thrilled to Receive a Travel Grant for ESMO TAT Asia25
Blog
May 9, 2025, 10:32
Julie Torode Believes That Collaboration Is Key to Ending Global Ovarian Cancer Inequities - WOCD
Blog
May 9, 2025, 10:29
Cathy Eng: Polyps Removed, so Back Again in 3 years
Blog
May 9, 2025, 10:15
Sarah Sammons Comments on TDXd Use in Early HER2+ Breast Cancer
Blog
May 9, 2025, 10:04
Aakash Desai: AI in Predicting EGFR Mutations from Whole Slide Images in Lung Cancer
Blog
May 9, 2025, 09:39
Yakup Ergün: One of the Key Upcoming Presentations at ESMO Breast 2025
Blog
May 9, 2025, 09:37
Erika Hamilton: PROTAC Data at ASCO25 in the MBC Oral Session
Blog
May 9, 2025, 09:29
ESO - M2ICOS Project Launches Fellowship Program to Support Oncology Training and Mobility in the EU
Science
May 9, 2025, 09:22
Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski
Drugs
May 9, 2025, 09:15
Penpulimab: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Drugs
May 9, 2025, 08:47
Jonathan Pachter: FDA Grants Accelerated Approval for 1st Targeted Therapy in KRAS-Mutant LGSOC
Blog
May 9, 2025, 08:15
Parminder Singh: Grand Rounds at Mayo Clinic